• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Secondary immunodeficiency as a consequence of chronic diseases].

作者信息

Chovancová Zita

出版信息

Vnitr Lek. 2019 Winter;65(2):117-124.

PMID:30909701
Abstract

Secondary immunodeficiencies (SID) represents heterogeneous group of acquired impairment of immune system function with diverse etiology. It is mostly a combined disorder of both humoral and cellular component of the innate and adaptive immune response. SID occurs mainly in adulthood. Among the most important causes of SID development belong diabetes mellitus, impairment of liver and kidney functions, protein-energy malnutrition, splenic defects and immunosenescence. These deficiencies of immunity are clinically manifested by an increased frequency or unusual complications of common infections and occasionally by the occurrence of opportunistic infections. Diagnostic procedure is based on blood count and differential leukocyte count, biochemical examination, including determination of total protein and albumin concentrations, and biochemical urine analysis to eliminate protein losses. If clinically significant secondary defect of the immune system is suspected, immunological examination is indicated. Patients with clinical symptoms of SID can be treated with prophylactic antibiotic therapy, vaccination, substitution immunoglobulin therapy, or by immune system modifiers.

摘要

相似文献

1
[Secondary immunodeficiency as a consequence of chronic diseases].
Vnitr Lek. 2019 Winter;65(2):117-124.
2
Overview of secondary immunodeficiency.继发性免疫缺陷概述。
Allergy Asthma Proc. 2024 Sep 1;45(5):347-354. doi: 10.2500/aap.2024.45.240063.
3
Secondary immunodeficiencies, including HIV infection.继发性免疫缺陷,包括 HIV 感染。
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S195-203. doi: 10.1016/j.jaci.2009.08.040. Epub 2009 Dec 29.
4
[Prophylactic and therapeutic management of increased susceptibility to infection in patients with immunodeficiency].[免疫缺陷患者感染易感性增加的预防和治疗管理]
Internist (Berl). 2022 May;63(5):484-492. doi: 10.1007/s00108-022-01326-8. Epub 2022 Apr 12.
5
6. Secondary immunodeficiencies, including HIV infection.6. 继发性免疫缺陷,包括HIV感染。
J Allergy Clin Immunol. 2008 Feb;121(2 Suppl):S388-92; quiz S417. doi: 10.1016/j.jaci.2007.06.003.
6
[Primary immunodeficiency].[原发性免疫缺陷]
Z Rheumatol. 2013 Sep;72(7):643-52. doi: 10.1007/s00393-013-1161-6.
7
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors.原发性和继发性免疫缺陷患者及健康供体对新冠病毒新抗原RBD的特异性细胞免疫和体液免疫反应
Biomedicines. 2023 Mar 28;11(4):1042. doi: 10.3390/biomedicines11041042.
8
Immunology Update: Primary Immunodeficiency Diseases.免疫学最新进展:原发性免疫缺陷病
FP Essent. 2016 Nov;450:35-53.
9
The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.阿拉伯联合酋长国先天性免疫缺陷疾病谱:三级医疗中心的5年经验
Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.
10
Pulmonary Manifestations of Primary Humoral Deficiencies.原发性体液免疫缺陷的肺部表现。
Can Respir J. 2022 Apr 10;2022:7140919. doi: 10.1155/2022/7140919. eCollection 2022.

引用本文的文献

1
Association Between COVID-19 and Diabetes Management Indices in Japanese Type 2 Diabetes Mellitus Patients: A Single-Center, Retrospective Study.日本2型糖尿病患者中COVID-19与糖尿病管理指标之间的关联:一项单中心回顾性研究
Infect Drug Resist. 2024 Aug 29;17:3759-3767. doi: 10.2147/IDR.S475917. eCollection 2024.
2
Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T).免疫功能低下患者的急性憩室炎:来自国际多中心观察性登记研究(基于网络的国际急诊外科创伤登记研究,Wires-T)的证据。
Tech Coloproctol. 2023 Sep;27(9):747-757. doi: 10.1007/s10151-023-02758-6. Epub 2023 Feb 7.
3
The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines.
免疫衰老与微生物群在疫苗效力中的相互作用
Vaccines (Basel). 2020 Nov 2;8(4):636. doi: 10.3390/vaccines8040636.